Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.

Namazy JA, Blais L, Andrews EB, Scheuerle AE, Cabana MD, Thorp JM, Umetsu DT, Veith JH, Sun D, Kaufman DG, Covington DL, Mukhopadhyay S, Fogel RB, Lopez-Leon S, Spain CV.

J Allergy Clin Immunol. 2019 May 27. pii: S0091-6749(19)30690-6. doi: 10.1016/j.jaci.2019.05.019. [Epub ahead of print]

2.

Guided asthma self-management or patient self-adjustment? Using patients' narratives to better understand adherence to asthma treatment.

Farnesi BC, Ducharme FM, Blais L, Collin J, Lavoie KL, Bacon SL, McKinney ML, Peláez S.

Patient Prefer Adherence. 2019 Apr 23;13:587-597. doi: 10.2147/PPA.S195585. eCollection 2019.

3.

Risk of Postpartum Depression Among Women with Asthma.

Blais L, Salah Ahmed SI, Beauchesne MF, Forget A, Kettani FZ, Lavoie KL.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):925-933.e2. doi: 10.1016/j.jaip.2018.09.026. Epub 2018 Oct 5.

PMID:
30292921
4.

Methods for the assessment of selection bias in drug safety during pregnancy studies using electronic medical data.

Schnitzer ME, Blais L.

Pharmacol Res Perspect. 2018 Sep 21;6(5):e00426. doi: 10.1002/prp2.426. eCollection 2018 Oct.

5.

A Bayesian finite mixture of bivariate regression model for causal mediation analyses.

Lefebvre G, Samoilenko M, Boucoiran I, Blais L.

Stat Med. 2018 Nov 10;37(25):3637-3660. doi: 10.1002/sim.7835. Epub 2018 Jun 11.

PMID:
29888477
6.
7.

Development of a graphical tool to measure medication adherence in asthma patients: A mixed-methods pilot study.

Yousif A, Lemière C, Cartier A, Forget A, Blais L.

J Asthma. 2019 May;56(5):543-552. doi: 10.1080/02770903.2018.1471702. Epub 2018 Jun 8.

PMID:
29746201
8.

Understanding and diagnosing the potential for bias when using machine learning methods with doubly robust causal estimators.

Bahamyirou A, Blais L, Forget A, Schnitzer ME.

Stat Methods Med Res. 2019 Jun;28(6):1637-1650. doi: 10.1177/0962280218772065. Epub 2018 May 2.

PMID:
29717941
9.

Patients' Perception of Newly Initiated Oral Anticoagulant Treatment for Atrial Fibrillation: an Observational Study.

Larochelle J, Brais C, Blais L, Perreault S, Farand P, Letemplier G, Beauchesne MF.

J Gen Intern Med. 2018 Aug;33(8):1239-1241. doi: 10.1007/s11606-018-4457-z. No abstract available.

10.

Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation.

Lavoie K, Turgeon MH, Brais C, Larochelle J, Blais L, Farand P, Letemplier G, Perreault S, Beauchesne MF.

J Atr Fibrillation. 2016 Dec 31;9(4):1478. doi: 10.4022/jafib.1478. eCollection 2016 Dec.

11.

Polypharmacy, chronic kidney disease, and benign prostatic hyperplasia in patients with chronic obstructive pulmonary disease newly treated with long-acting anticholinergics.

Savaria F, Beauchesne MF, Forget A, Blais L.

Respir Med. 2017 Nov;132:195-202. doi: 10.1016/j.rmed.2017.10.023. Epub 2017 Oct 31. No abstract available.

12.

Preferences and Inhalation Techniques for Inhaler Devices Used by Patients with Chronic Obstructive Pulmonary Disease.

Bournival R, Coutu R, Goettel N, Yang CD, Cantin-Lafleur A, Lemieux C, Lévesque AM, Patenaude-Monette JF, Roy FO, Blais L, Arbour F, Fillion A, Beauchesne MF.

J Aerosol Med Pulm Drug Deliv. 2018 Aug;31(4):237-247. doi: 10.1089/jamp.2017.1409. Epub 2017 Dec 5.

PMID:
29206566
13.

Long-Acting β2-Agonists and Risk of Hypertensive Disorders of Pregnancy: A Cohort Study.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C, Rey E.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):555-561.e2. doi: 10.1016/j.jaip.2017.07.004. Epub 2017 Aug 26.

PMID:
28847655
14.

[Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006].

Carrier JD, Blais L, Cohen A, Courteau J, Roberge P, Larouche A, Grignon S, Fleury MJ, Lesage A, Demers MF, Roy MA, Delorme A, Vanasse A.

Sante Ment Que. Spring 2017;42(1):85-103. French.

PMID:
28792563
15.

Adherence and Persistence to Long-Acting Anticholinergics Treatment Episodes in Patients With Chronic Obstructive Pulmonary Disease.

Savaria F, Beauchesne MF, Forget A, Blais L.

Ann Pharmacother. 2017 Dec;51(12):1063-1068. doi: 10.1177/1060028017723349. Epub 2017 Jul 31.

PMID:
28760010
16.

Characterization of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Qualitative Analysis.

Rodrigue C, Beauchesne MF, Mallette V, Lemière C, Larivée P, Blais L.

COPD. 2017 Jun;14(3):330-338. doi: 10.1080/15412555.2017.1318841. Epub 2017 May 11.

PMID:
28494181
17.

Psychosocial determinants of non-adherence to antidiabetic drug treatment: A prospective cohort study.

Guénette L, Zongo A, Guillaumie L, Lauzier S, Blais L, Grégoire JP, Moisan J.

Diabetes Metab. 2017 Sep;43(4):368-372. doi: 10.1016/j.diabet.2017.03.005. Epub 2017 May 5. No abstract available.

PMID:
28483291
18.

Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.

Brais C, Larochelle J, Turgeon MH, Blais L, Farand P, Perreault S, Letemplier G, Beauchesne MF.

J Pharm Pharm Sci. 2017;20:8-14. doi: 10.18433/J30W4F.

19.

Enablers and determinants of the provision of written action plans to patients with asthma: a stratified survey of Canadian physicians.

Djandji F, Lamontagne AJ, Blais L, Bacon SL, Ernst P, Grad R, Lavoie KL, McKinney ML, Desplats E, Ducharme FM.

NPJ Prim Care Respir Med. 2017 Mar 31;27(1):21. doi: 10.1038/s41533-017-0012-3.

20.

Challenging body weight: evidence from a community-based intervention on weight, behaviour and motivation.

Blais LT, Mack DE, Wilson PM, Blanchard CM.

Psychol Health Med. 2017 Aug;22(7):872-878. doi: 10.1080/13548506.2016.1271440. Epub 2016 Dec 21.

PMID:
27998180
21.

Physician agreement regarding the expansion of pharmacist professional activities in the management of patients with asthma.

Tilly-Gratton A, Lamontagne A, Blais L, Bacon SL, Ernst P, Grad R, Lavoie KL, McKinney ML, Desplats E, Ducharme FM.

Int J Pharm Pract. 2017 Oct;25(5):335-342. doi: 10.1111/ijpp.12320. Epub 2016 Oct 24.

PMID:
27774739
22.

Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C, Ducharme FM.

Eur J Clin Pharmacol. 2017 Jan;73(1):91-97. doi: 10.1007/s00228-016-2139-5. Epub 2016 Oct 1.

PMID:
27695918
23.

The use of asthma controller medications during pregnancy and the risk of gestational diabetes.

Baribeau V, Beauchesne MF, Rey É, Forget A, Blais L.

J Allergy Clin Immunol. 2016 Dec;138(6):1732-1733.e6. doi: 10.1016/j.jaci.2016.06.031. Epub 2016 Jul 27. No abstract available.

PMID:
27569749
24.

mHealth Intervention to Improve Diabetes Risk Behaviors in India: A Prospective, Parallel Group Cohort Study.

Pfammatter A, Spring B, Saligram N, Davé R, Gowda A, Blais L, Arora M, Ranjani H, Ganda O, Hedeker D, Reddy S, Ramalingam S.

J Med Internet Res. 2016 Aug 5;18(8):e207. doi: 10.2196/jmir.5712.

25.

Ovarian Stimulation, Intrauterine Insemination, Multiple Pregnancy and Major Congenital Malformations: A Systematic Review and Meta- Analysis- The ART_Rev Study.

Chaabane S, Sheehy O, Monnier P, Fraser W, Bissonnette F, Trasler JM, Muanda FT, Boukhris T, Karam F, Santos F, Blais L, Bérard A.

Curr Drug Saf. 2016;11(3):222-61. Review.

PMID:
27484228
26.

Enablers of Physician Prescription of a Long-Term Asthma Controller in Patients with Persistent Asthma.

Ducharme FM, Lamontagne AJ, Blais L, Grad R, Lavoie KL, Bacon SL, McKinney ML, Desplats E, Ernst P.

Can Respir J. 2016;2016:4169010. doi: 10.1155/2016/4169010. Epub 2016 Jun 15.

27.

The Impact of Different Case Ascertainment Definitions on the Prevalence of Major Congenital Malformations and their Association with Asthma During Pregnancy.

Eltonsy S, Forget A, Blais L.

Matern Child Health J. 2017 Mar;21(3):616-625. doi: 10.1007/s10995-016-2147-1.

PMID:
27443652
28.

Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.

Vanasse A, Blais L, Courteau J, Cohen AA, Roberge P, Larouche A, Grignon S, Fleury MJ, Lesage A, Demers MF, Roy MA, Carrier JD, Delorme A.

Acta Psychiatr Scand. 2016 Nov;134(5):374-384. doi: 10.1111/acps.12621. Epub 2016 Jul 12.

PMID:
27404582
29.

Maternal inhaled fluticasone propionate intake during pregnancy is detected in neonatal cord blood.

Battista MC, Boutin M, Venne P, Blais L, Bérard A, Lacroix M, Patenaude J, Guillemette L, Cossette B, Hivert MF, Auray-Blais C.

Bioanalysis. 2016 Jul;8(14):1441-1450. Epub 2016 Jun 28.

PMID:
27349687
30.

Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans.

Després F, Forget A, Kettani FZ, Blais L.

J Manag Care Spec Pharm. 2016 May;22(5):539-47. doi: 10.18553/jmcp.2016.22.5.539.

31.

Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.

Renoux C, Dell'Aniello S, Khairy P, Marras C, Bugden S, Turin TC, Blais L, Tamim H, Evans C, Steele R, Dormuth C, Ernst P; Canadian Network for Observational Drug Effect Studies (CNODES) investigators.

Br J Clin Pharmacol. 2016 Aug;82(2):461-72. doi: 10.1111/bcp.12964. Epub 2016 May 19.

32.

Asthma during pregnancy and congenital malformations: The challenging task of separating the medication effect from asthma itself.

Eltonsy S, Blais L.

J Allergy Clin Immunol. 2016 May;137(5):1623-4. doi: 10.1016/j.jaci.2015.11.049. Epub 2016 Mar 21. No abstract available.

PMID:
27012642
33.

Systematic procedure for the classification of proven and potential teratogens for use in research.

Eltonsy S, Martin B, Ferreira E, Blais L.

Birth Defects Res A Clin Mol Teratol. 2016 Apr;106(4):285-97. doi: 10.1002/bdra.23491. Epub 2016 Mar 11.

PMID:
26969841
34.

Adverse events among COPD patients treated with long-acting anticholinergics and β2-agonists in an outpatient respiratory clinic.

Rodrigue C, Beauchesne MF, Savaria F, Forget A, Lemière C, Larivée P, Blais L; RESP Investigators.

Respir Med. 2016 Apr;113:65-73. doi: 10.1016/j.rmed.2016.02.002. Epub 2016 Feb 9.

35.

Relative associations between depression and anxiety on adverse cardiovascular events: does a history of coronary artery disease matter? A prospective observational study.

Pelletier R, Bacon SL, Arsenault A, Dupuis J, Laurin C, Blais L, Lavoie KL.

BMJ Open. 2015 Dec 15;5(12):e006582. doi: 10.1136/bmjopen-2014-006582.

36.

Patterns and Predictors of Use of Anticoagulants for the Treatment of Venous Thromboembolism Following Approval of Rivaroxaban.

Dault R, Vanasse A, Blais L, Perreault S, Farand P, Le Templier G, Beauchesne MF.

Clin Appl Thromb Hemost. 2016 Nov;22(8):765-771. Epub 2015 Oct 14.

PMID:
26467323
37.

Antimalarial drugs for preventing malaria during pregnancy and the risk of low birth weight: a systematic review and meta-analysis of randomized and quasi-randomized trials.

Muanda FT, Chaabane S, Boukhris T, Santos F, Sheehy O, Perreault S, Blais L, Bérard A.

BMC Med. 2015 Aug 14;13:193. doi: 10.1186/s12916-015-0429-x. Review.

38.

Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.

Peláez S, Lamontagne AJ, Collin J, Gauthier A, Grad RM, Blais L, Lavoie KL, Bacon SL, Ernst P, Guay H, McKinney ML, Ducharme FM.

BMC Pulm Med. 2015 Apr 25;15:42. doi: 10.1186/s12890-015-0044-9.

39.

Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C.

Thorax. 2015 Jul;70(7):647-52. doi: 10.1136/thoraxjnl-2014-206634. Epub 2015 Apr 17.

PMID:
25888364
40.

Treatment of Clostridium difficile infection in a French university hospital.

Khanafer N, Blais L, Barbut F, Hirschel B, Vanhems P.

Scand J Gastroenterol. 2015;50(10):1253-60. doi: 10.3109/00365521.2015.1033746. Epub 2015 Apr 15.

PMID:
25877477
41.

Is drug insurance status an effect modifier in epidemiologic database studies? The case of maternal asthma and major congenital malformations.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C.

Birth Defects Res A Clin Mol Teratol. 2015 Dec;103(12):995-1002. doi: 10.1002/bdra.23366. Epub 2015 Apr 6.

PMID:
25846426
42.

Patterns of oral anticoagulants use in atrial fibrillation.

Brais C, Larochelle J, Turgeon M, Tousignant A, Blais L, Perreault S, Farand P, Letemplier G, Beauchesne M.

J Popul Ther Clin Pharmacol. 2015;22(1):e90-5. Epub 2015 Feb 23.

PMID:
25715385
43.

Accuracy of the days' supply and the number of refills allowed recorded in Québec prescription claims databases for inhaled corticosteroids.

Blais L, Vilain A, Kettani FZ, Forget A, Lalonde G, Beauchesne MF, Ducharme FM, Lemière C.

BMJ Open. 2014 Nov 28;4(11):e005903. doi: 10.1136/bmjopen-2014-005903.

44.

Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial.

Lavoie KL, Moullec G, Lemiere C, Blais L, Labrecque M, Beauchesne MF, Pepin V, Cartier A, Bacon SL.

Patient Prefer Adherence. 2014 Nov 10;8:1555-69. doi: 10.2147/PPA.S66966. eCollection 2014.

45.

Outcome of work-related asthma exacerbations in Quebec and Ontario.

Lemière C, To T, de Olim C, Ribeiro M, Liss G, Lougheed MD, Hoy R, Forget A, Blais L, Zhu J, Tarlo SM.

Eur Respir J. 2015 Jan;45(1):266-8. doi: 10.1183/09031936.00096114. Epub 2014 Oct 30. No abstract available.

46.

Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.

Eltonsy S, Forget A, Beauchesne MF, Blais L.

J Allergy Clin Immunol. 2015 Jan;135(1):123-30. doi: 10.1016/j.jaci.2014.07.051. Epub 2014 Sep 13.

PMID:
25226849
47.

Systemic corticosteroids for the treatment of asthma exacerbations during and outside of pregnancy in an acute-care setting.

Cossette B, Beauchesne MF, Forget A, Lemière C, Larivée P, Rey É, Couturier M, Rodrigue C, Blais L.

Respir Med. 2014 Sep;108(9):1260-7. doi: 10.1016/j.rmed.2014.07.001. Epub 2014 Jul 11.

48.

Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.

Cossette B, Beauchesne MF, Forget A, Lemière C, Larivée P, Rey E, Blais L.

Ann Allergy Asthma Immunol. 2014 May;112(5):459-64. doi: 10.1016/j.anai.2014.02.010. Epub 2014 Mar 19.

PMID:
24656659
49.

Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.

Després F, Perreault S, Lalonde L, Forget A, Kettani FZ, Blais L.

Can J Cardiol. 2014 May;30(5):560-7. doi: 10.1016/j.cjca.2013.11.032. Epub 2013 Dec 10.

PMID:
24613090
50.

Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data.

Lipscombe LL, Austin PC, Alessi-Severini S, Blackburn DF, Blais L, Bresee L, Filion KB, Kawasumi Y, Kurdyak P, Platt RW, Tamim H, Paterson JM; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

Schizophr Res. 2014 Apr;154(1-3):54-60. doi: 10.1016/j.schres.2014.01.043. Epub 2014 Feb 24.

Supplemental Content

Support Center